⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ENSC News
Ensysce Biosciences, Inc. Common Stock
Ensysce Biosciences Issues Annual Shareholder Letter
accessnewswire.com
ENSC
Diamond Equity Research Releases Update Note on Ensysce Biosciences, Inc. (NASDAQ: ENSC)
globenewswire.com
ENSC
Ensysce Biosciences Achieves Major Milestone with Initiation of Enrollment in Pivotal Phase 3 Trial of PF614, Its Next-Generation Opioid
accessnewswire.com
ENSC
Ensysce Biosciences Announces Broader Patent Protection for Groundbreaking MPAR(R) Overdose Protection Technology
accessnewswire.com
ENSC
Ensysce Biosciences Receives Positive FDA Feedback on PF614 Manufacturing Approach
accessnewswire.com
ENSC
Ensysce Biosciences Secures $4 Million Financing, Unlocking Up to $20 Million in Total Financing to Advance Breakthrough Pain Programs
accessnewswire.com
ENSC
Ensysce Biosciences Reports Third Quarter 2025 Financial Results
accessnewswire.com
ENSC
Ensysce Biosciences Releases Symposium Highlights from PAINWeek 2025
accessnewswire.com
ENSC
Ensysce Biosciences Showcases Urgent Need for Safer Opioids at PAINWeek 2025 Symposium
accessnewswire.com
ENSC